Condition
Camrelizumab clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Camrelizumab clinical trials that are recruiting, in China. By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Camrelizumab clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Interferon-gamma plus camrelizumab with chemotherapy before surgery for locally advanced esophageal squamous cell carcinoma | Phase 2 | Hefei, Anhui and 1 other locations | Recruiting | Aug 26, 2026 |
| Combining TACE with Camrelizumab and Apatinib for Liver Cancer | Phase 3 | Chengdu, Sichuan | Recruiting | Jul 3, 2024 |
| Combination therapy for high-risk acral melanoma before surgery | Phase 2 | Beijing, Beijing Municipality | Recruiting | Aug 23, 2022 |
| Combining Camrelizumab with TCb for treating triple-negative breast cancer | Phase 2 | Zhengzhou, Henan | Recruiting | Jul 27, 2022 |
All recruiting trials (4)
-
Interferon-gamma plus camrelizumab with chemotherapy before surgery for locally advanced esophageal squamous cell carcinoma
This trial tests whether giving interferon-gamma with camrelizumab and chemotherapy before surgery helps patients with locally advanced esophageal squamous cell carcinoma.
-
Combining TACE with Camrelizumab and Apatinib for Liver Cancer
This study is testing if combining a liver cancer treatment called TACE with two drugs, camrelizumab and apatinib, can help people with advanced liver cancer live longer and feel better compared to standard treatments.
-
Combination therapy for high-risk acral melanoma before surgery
This study is testing a new combination of treatments before surgery to see if it can help people with high-risk acral melanoma have better outcomes.
-
Combining Camrelizumab with TCb for treating triple-negative breast cancer
This study is testing if combining a new drug called camrelizumab with a chemotherapy treatment can help people with triple-negative breast cancer do better after surgery.
Related topics
Quick answers
How many Camrelizumab clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.